BUCET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bucet, and what generic alternatives are available?
Bucet is a drug marketed by Mallinckrodt and is included in one NDA.
The generic ingredient in BUCET is acetaminophen; butalbital. There are sixty-six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BUCET?
- What are the global sales for BUCET?
- What is Average Wholesale Price for BUCET?
Summary for BUCET
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BUCET at DailyMed |
![BUCET drug patent expirations Drug patent expirations by year for BUCET](/p/graph/s/t/BUCET-patent-expirations.png)
US Patents and Regulatory Information for BUCET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mallinckrodt | BUCET | acetaminophen; butalbital | CAPSULE;ORAL | 088991-001 | Jun 28, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |